Comparative Effectiveness of Emerging Medications in Children with Inflammatory Bowel Disease (COMPARE)
Crohn’s disease (CD) and ulcerative colitis (UC) are chronic inflammatory bowel diseases (IBDs) that affect approximately 1.2 million individuals in the United States, cost over $6 billion annually, and cause substantial patient morbidity, missed work and school, and diminished quality of life. Pediatric onset IBD (PIBD) is a distinct entity, often presenting with more severe […]